12:00 AM
 | 
Jun 17, 2013
 |  BioCentury  |  Finance

Breaching Myriad's walls

Myriad shares jump, then slump on fast moving competition following SCOTUS
Breaching Myriad's walls

Myriad Genetics Inc. (NASDAQ:MYGN) jumped more than 10% in intraday trading Thursday as the company claimed victory on a U.S. Supreme Court ruling allowing cDNA patents. But the shares ended the day down 6% and tumbled further Friday after several companies announced plans to offer competing breast cancer tests priced as low as one-third of Myriad's BRACAnalysis test.

In a...

Read the full 296 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >